Meg Jardine's Publications

• Digital health technologies to support medication adherence in chronic kidney disease

  Journal articles

  2022

  Nephrology

• Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program

  Journal articles

  2022

  Diabetes, Obesity and Metabolism

• Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

  Journal articles

  2022

  Trials

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  Journal articles

  2022

  The Lancet

• Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

  Journal articles

  2022

  Journal of the American College of Cardiology

• CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL

  Conference Abstracts

  2022

  NEPHROLOGY

• Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

  Journal articles

  2022

  Journal of the American Heart Association

• SGLT2 inhibitors and finerenone: one or the other or both?

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

  Journal articles

  2022

  Diabetes and Metabolism

• Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis

  Journal articles

  2022

  Clinical Kidney Journal

• Trimming the fat: Is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review

  Journal articles

  2022

  Clinical Kidney Journal

• Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial

  Journal articles

  2022

  JAMA - Journal of the American Medical Association

• Risk factors for incident kidney disease in older adults: an Australian prospective population-based study

  Journal articles

  2022

  Internal Medicine Journal

• A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

  Journal articles

  2022

  Frontiers in Cardiovascular Medicine

• Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

  Journal articles

  2022

  Journal of the American Society of Nephrology

• Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice

  Journal articles

  2022

  International Journal of Cardiology

• SGLT2 inhibitors may prevent diabetes

  Journal articles

  2022

  Nature Reviews Nephrology

• Digital health and artificial intelligence in kidney research: A report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• Prior Cardiovascular TreatmentsA Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

  Journal articles

  2022

  Frontiers in Pharmacology

• Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

  Journal articles

  2022

  Clinical Journal of the American Society of Nephrology

• Antiplatelet agents for chronic kidney disease

  Journal articles

  2022

  Cochrane Database of Systematic Reviews

• GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

  Journal articles

  2022

  Kidney International

• Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

  Journal articles

  2022

  American Journal of Kidney Diseases

• Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study

  Journal articles

  2022

  Canadian Journal of Kidney Health and Disease

• Dialysis Dose and Adequacy for Hemodialysis

  Book Chapters

  2022

  Evidence-Based Nephrology, Second Edition: Volumes 1,2

• Alternative Clinical Trial Designs for Nephrology Research

  Book Chapters

  2022

  Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care